Analyst Reco. AbbVie Inc. Buenos Aires S.E.

Equities

ABBVD

ARBCOM4603M9

End-of-day quote Buenos Aires S.E. Other stock markets 03:30:00 27/06/2024 am IST			5-day change	1st Jan Change
18.05 ^USD	+4.64%		+6.18%	+18.75%

28/06	Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU	MT
28/06	AbbVie, Genmab Receive Positive European Opinion on Marketing Authorization for Possible Lymphoma Treatment	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Piper Sandler Adjusts Price Target on AbbVie to $190 From $185	18/06	MT
AbbVie Says Investors Should Sit Out Tutanota Mini-Tender Offer	15/06	MT
HSBC Upgrades AbbVie to Buy From Hold, Adjusts Price Target to $185 From $161	05/06	MT
ANALYST RECOMMENDATIONS : Abbvie, Air Products, Applied Materials, KLA Corporation, UnitedHealth...	05/06
Cantor Fitzgerald Initiates AbbVie at Overweight Rating With $200 Price Target	17/05	MT
ANALYST RECOMMENDATIONS : Walmart, Netflix, Abbvie, Delta...	17/05
Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190	08/05	MT
BMO Capital Cuts Price Target on AbbVie to $180 From $195, Maintains Outperform Rating	29/04	MT
Morgan Stanley Adjusts AbbVie's Price Target to $191 From $196	29/04	MT
Barclays Adjusts Price Target on AbbVie to $187 From $195	29/04	MT
Deutsche Bank Raises AbbVie's Price Target to $175 Form $170	19/04	MT
Barclays Raises AbbVie Price Target to $195 From $185, Maintains Overweight Rating	27/03	MT
Abbvie Insider Sold Shares Worth $3,716,757, According to a Recent SEC Filing	23/03	MT
Abbvie Insider Sold Shares Worth $10,539,508, According to a Recent SEC Filing	21/03	MT
ANALYST RECOMMENDATIONS : Abbvie, Align Technology; Ulta Beauty, United Airlines, Currys...	15/03
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox...	26/02
Mizuho Raises Price Target on Cerevel Therapeutics to $45 From $25 to Reflect Sale Price to AbbVie, Keeps Neutral Rating	15/02	MT
UBS Adjusts Price Target on AbbVie to $172 from $165, Maintains Neutral Rating	06/02	MT
Truist Adjusts Price Target on AbbVie to $195 From $180, Maintains Buy Rating	06/02	MT
Piper Sandler Adjusts Price Target on AbbVie to $185 From $180, Maintains Overweight Rating	05/02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. AbbVie Inc. Buenos Aires S.E.

Equities

ABBVD

ARBCOM4603M9

Analyst Reco.

Filters